Clinical Pathways GPS
02/22/2019
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Matthew Pakizegee, PharmD, MS
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure...
Determining how to pay for the treatment of uncommon yet serious diseases is an important consideration in terms of sustainability and patient access. Novel and expensive therapies will create financial pressure...
...
02/22/2019
Journal of Clinical Pathways